Intrexon Corp (XON) Files $125M IPO

July 9, 2013 4:20 PM EDT
Intrexon Corporation (NYSE: XON) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $125 million. The company plans to list on the New York Stock Exchange under the ticker, "XON."

The offering is being made via JPMorgan and Barclays.

Revs for the three-months ended March 31, 2013, were $3.976 million, from $1.618 million in the same period last year. Net loss widened from $13.912 million out to $36.311 million, or $4.31 per share over that period.

Intrexon believes it is a leader in the field of synthetic biology, an emerging and rapidly evolving discipline that applies engineering principles to biological systems.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

JPMorgan, Barclays

Add Your Comment